Viewing Study NCT01202435


Ignite Creation Date: 2025-12-24 @ 10:44 PM
Ignite Modification Date: 2026-05-30 @ 6:15 AM
Study NCT ID: NCT01202435
Status: COMPLETED
Last Update Posted: 2021-01-22
First Post: 2010-09-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Investigation Of The Absorption And Pharmacokinetics Of Multiple Doses Of A Controlled Release Pregabalin Tablet As Compared To Multiple Doses Of The Immediate Release Pregabalin Capsule
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None pregabalin View
None pharmacokinetics View
None bioavailability View
None bioequivalence View